Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H M Jansen

Showing results (211-220 of 251) with videos related to

Pageof 26
Sort By:
Breast Cancer Research and Treatment|November 19, 2011
High miR-26a and low CDC2 levels associate with decreased EZH2 expression and with favorable outcome on tamoxifen in metastatic breast cancerM P H M Jansen, E A Reijm, A M Sieuwerts, et al.
European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology|September 11, 2007
The influence of myocardial scar and dyssynchrony on reverse remodeling in cardiac resynchronization therapyAnnemieke H M Jansen, Frank Bracke, Jan Melle van Dantzig, et al.
Scientific Reports|May 20, 2017
Somatic Tumor Mutations Detected by Targeted Next Generation Sequencing in Minute Amounts of Serum-Derived Cell-Free DNAMarjolein J A Weerts, Ronald van Marion, Jean C A Helmijr, et al.
Cancer Treatment and Research Communications|March 28, 2025
Genome-wide cell-free DNA methylation profiling in advanced stage ovarian cancer. Are we looking at the tumor or the patient's immune response to the tumor?Caroline B van den Berg, Gatske M Nieuwenhuyzen-de Boer, Ingrid A Boere, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2008
Association of an extracellular matrix gene cluster with breast cancer prognosis and endocrine therapy responseJozien Helleman, Maurice P H M Jansen, Kirsten Ruigrok-Ritstier, et al.
Molecular Oncology|October 18, 2020
Comparison of variant allele frequency and number of mutant molecules as units of measurement for circulating tumor DNAManouk K Bos, Kazem Nasserinejad, Maurice P H M Jansen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 7, 2014
High protein expression of EZH2 is related to unfavorable outcome to tamoxifen in metastatic breast cancerE A Reijm, A M Timmermans, M P Look, et al.
Cancer Research|November 19, 2013
Hallmarks of aromatase inhibitor drug resistance revealed by epigenetic profiling in breast cancerMaurice P H M Jansen, Theo Knijnenburg, Esther A Reijm, et al.
The American Journal of Cardiology|April 3, 2007
Qualitative observation of left ventricular multiphasic septal motion and septal-to-lateral apical shuffle predicts left ventricular reverse remodeling after cardiac resynchronization therapyAnnemieke H M Jansen, Jan melle van Dantzig, Franck Bracke, et al.
British Journal of Haematology|February 23, 2018
New insights in Type I and II CD20 antibody mechanisms-of-action with a panel of novel CD20 antibodiesSaskia Meyer, Mitchell Evers, Johannes H M Jansen, et al.
Pageof 26

Showing results (211-220 of 251) with videos related to

Sort By:
Pageof 26
Breast Cancer Research and Treatment|November 19, 2011
High miR-26a and low CDC2 levels associate with decreased EZH2 expression and with favorable outcome on tamoxifen in metastatic breast cancerM P H M Jansen, E A Reijm, A M Sieuwerts, et al.
European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology|September 11, 2007
The influence of myocardial scar and dyssynchrony on reverse remodeling in cardiac resynchronization therapyAnnemieke H M Jansen, Frank Bracke, Jan Melle van Dantzig, et al.
Scientific Reports|May 20, 2017
Somatic Tumor Mutations Detected by Targeted Next Generation Sequencing in Minute Amounts of Serum-Derived Cell-Free DNAMarjolein J A Weerts, Ronald van Marion, Jean C A Helmijr, et al.
Cancer Treatment and Research Communications|March 28, 2025
Genome-wide cell-free DNA methylation profiling in advanced stage ovarian cancer. Are we looking at the tumor or the patient's immune response to the tumor?Caroline B van den Berg, Gatske M Nieuwenhuyzen-de Boer, Ingrid A Boere, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2008
Association of an extracellular matrix gene cluster with breast cancer prognosis and endocrine therapy responseJozien Helleman, Maurice P H M Jansen, Kirsten Ruigrok-Ritstier, et al.
Molecular Oncology|October 18, 2020
Comparison of variant allele frequency and number of mutant molecules as units of measurement for circulating tumor DNAManouk K Bos, Kazem Nasserinejad, Maurice P H M Jansen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 7, 2014
High protein expression of EZH2 is related to unfavorable outcome to tamoxifen in metastatic breast cancerE A Reijm, A M Timmermans, M P Look, et al.
Cancer Research|November 19, 2013
Hallmarks of aromatase inhibitor drug resistance revealed by epigenetic profiling in breast cancerMaurice P H M Jansen, Theo Knijnenburg, Esther A Reijm, et al.
The American Journal of Cardiology|April 3, 2007
Qualitative observation of left ventricular multiphasic septal motion and septal-to-lateral apical shuffle predicts left ventricular reverse remodeling after cardiac resynchronization therapyAnnemieke H M Jansen, Jan melle van Dantzig, Franck Bracke, et al.
British Journal of Haematology|February 23, 2018
New insights in Type I and II CD20 antibody mechanisms-of-action with a panel of novel CD20 antibodiesSaskia Meyer, Mitchell Evers, Johannes H M Jansen, et al.
Pageof 26